IL162789A0 - Peptide furification - Google Patents

Peptide furification

Info

Publication number
IL162789A0
IL162789A0 IL16278902A IL16278902A IL162789A0 IL 162789 A0 IL162789 A0 IL 162789A0 IL 16278902 A IL16278902 A IL 16278902A IL 16278902 A IL16278902 A IL 16278902A IL 162789 A0 IL162789 A0 IL 162789A0
Authority
IL
Israel
Prior art keywords
sub
solvent
water
mixture
decapeptide
Prior art date
Application number
IL16278902A
Other languages
English (en)
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Publication of IL162789A0 publication Critical patent/IL162789A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16278902A 2001-12-29 2002-12-23 Peptide furification IL162789A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0104462A SE0104462D0 (sv) 2001-12-29 2001-12-29 Peptide purifcation (Peptidrening)
PCT/IB2002/005581 WO2003055900A1 (en) 2001-12-29 2002-12-23 Peptide purification

Publications (1)

Publication Number Publication Date
IL162789A0 true IL162789A0 (en) 2005-11-20

Family

ID=20286556

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16278902A IL162789A0 (en) 2001-12-29 2002-12-23 Peptide furification
IL162789A IL162789A (en) 2001-12-29 2004-06-29 Peptide purification

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL162789A IL162789A (en) 2001-12-29 2004-06-29 Peptide purification

Country Status (18)

Country Link
US (1) US7057014B2 (enExample)
EP (1) EP1468009B1 (enExample)
JP (1) JP4378173B2 (enExample)
KR (1) KR100880828B1 (enExample)
CN (1) CN1272341C (enExample)
AT (1) ATE449784T1 (enExample)
AU (1) AU2002347550B2 (enExample)
CA (1) CA2471717C (enExample)
DE (1) DE60234535D1 (enExample)
DK (1) DK1468009T3 (enExample)
ES (1) ES2350880T3 (enExample)
IL (2) IL162789A0 (enExample)
NO (1) NO329024B1 (enExample)
NZ (1) NZ534151A (enExample)
RU (1) RU2303040C2 (enExample)
SE (1) SE0104462D0 (enExample)
WO (1) WO2003055900A1 (enExample)
ZA (1) ZA200405135B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1359722A1 (en) * 2002-03-27 2003-11-05 BRITISH TELECOMMUNICATIONS public limited company Data streaming system and method
EP1845973B1 (en) 2005-01-21 2015-08-12 Astex Therapeutics Limited Pharmaceutical compounds
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
JP2011520844A (ja) * 2008-05-15 2011-07-21 ノボ・ノルデイスク・エー/エス 固相合成法により調製されたペプチドの精製
ES2439998T3 (es) * 2009-04-10 2014-01-27 Corden Pharma Colorado, Inc. Procedimiento para aislar linaclotida
US9931417B2 (en) 2012-12-13 2018-04-03 Immunomedics, Inc. Antibody-SN-38 immunoconjugates with a CL2A linker
HRP20220399T1 (hr) 2012-12-13 2022-05-13 Immunomedics, Inc. Režim doziranja imunokonjugata protutijela i sn-38 za poboljšanu učinkovitost i smanjenu toksičnost
WO2015012904A2 (en) 2012-12-13 2015-01-29 Immunomedics, Inc. Antibody-sn-38 immunoconjugates with a cl2a linker
CN110075295A (zh) * 2013-07-23 2019-08-02 免疫医疗公司 具有cl2a接头的抗体-sn-38免疫缀合物
CN109310385A (zh) 2016-04-27 2019-02-05 免疫医疗公司 抗trop-2-sn-38抗体药物缀合物用于检查点抑制剂复发/难治的肿瘤的疗法的功效
CA3050332A1 (en) 2017-03-27 2018-10-04 Immunomedics, Inc. Treatment of trop-2 expressing triple negative breast cancer with sacituzumab govitecan and a rad51 inhibitor
EP3606964A4 (en) 2017-04-03 2020-12-09 Immunomedics, Inc. SUBCUTANE ADMINISTRATION OF ANTIBODY DRUG CONJUGATES FOR CANCER THERAPY
CN113952944B (zh) * 2021-12-23 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种纯化九肽-1的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317697D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Dissolution of peptides in non-aqueous and mixed non-aqueous/aqueous solvents
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
DE19813849A1 (de) * 1998-03-27 1999-09-30 Degussa Verfahren zur einstufigen Umsalzung und Aufreinigung von Oligopeptiden
EP0998940A1 (en) 1998-09-30 2000-05-10 Laboratoire Theramex Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
RU2004119965A (ru) 2006-01-10
CA2471717A1 (en) 2003-07-10
DE60234535D1 (de) 2010-01-07
CA2471717C (en) 2013-06-18
NZ534151A (en) 2007-05-31
KR100880828B1 (ko) 2009-01-30
ES2350880T3 (es) 2011-01-27
CN1272341C (zh) 2006-08-30
NO20043046L (no) 2004-08-30
AU2002347550A1 (en) 2003-07-15
US20060014694A1 (en) 2006-01-19
WO2003055900A1 (en) 2003-07-10
ATE449784T1 (de) 2009-12-15
RU2303040C2 (ru) 2007-07-20
CN1625561A (zh) 2005-06-08
AU2002347550B2 (en) 2008-01-03
SE0104462D0 (sv) 2001-12-29
DK1468009T3 (da) 2010-04-06
EP1468009B1 (en) 2009-11-25
NO329024B1 (no) 2010-08-02
JP2005515217A (ja) 2005-05-26
US7057014B2 (en) 2006-06-06
JP4378173B2 (ja) 2009-12-02
IL162789A (en) 2010-04-29
HK1076112A1 (en) 2006-01-06
ZA200405135B (en) 2005-08-31
EP1468009A1 (en) 2004-10-20
KR20040090966A (ko) 2004-10-27

Similar Documents

Publication Publication Date Title
IL162789A0 (en) Peptide furification
CA2373554A1 (en) Process for the preparation and purification of thiol-containing maytansinoids
CN101553574B (zh) 制备视黄酯的方法
MY142836A (en) Self-extinguishing catalyst composition with monocarboxylic acid ester internal donor and propylene polymerization process
CA2167294A1 (en) Fuel blends
SI1515962T1 (sl) Postopek za pripravo dioksan estrov ocetne kisline
BG104696A (en) PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
EP1568740A3 (en) Thickening systems and aqueous-coating compositions, and methods of making and using the same
CA2410451A1 (en) Clarification method for oil dispersions comprising overbased detergents containing calcite
EP0925065A4 (en) WATER-MISCIBLE ERYTHROMYCIN SOLUTIONS
AU552050B2 (en) N-substituted azeheterocyclic carboxylic acids and their esters
CS212284B2 (en) Method of making the 1,1-dioxides of the acetoxymethylpenam derivatives
Ko et al. Generation of Diphenyldiazomethane by Oxidation of Benzophenone Hydrazone with Magtrieve [TM]
EP0924187A3 (en) Organic ester plasticizers
ATE258911T1 (de) Verfahren zur herstellung von alkoxyzimtsäureester
Tabushi et al. Photoreduction of keto carboxylic acid derivatives to oxyacid derivatives catalyzed by ZnTPPS [zinc tetraphenylporphyrintetrasulfonate]-quinolinium-3-carboxamide-CTAB micelle
IL141091A0 (en) Substituted cinnamic acids and cinnamic acids esters
CA2573129A1 (en) Process for preparing levofloxacin or its hydrate
BR0013944A (pt) Processo para a prepapação de um éster de aril carboxilato
Aurell et al. Dienediolates of Unsaturated Carboxylic Acids in Synthesis. Tandem Michael Diechmann Synthesis of Substituted 2-Cyclohexenones
GB9914382D0 (en) New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
RU2000114008A (ru) Способ выделения кислот из углеводородных смесей
BG95616A (bg) Метод за увеличаване на алфа към бета съотношението в аспертаминова купелуваща реакция
NO20013528D0 (no) Fremgangsmåte for reduksjon av 3-dimetylamino-2- fenylpropionsyre-etylester-innhold i lösninger av 2-dimetylamino-1-fenyl-3-cykloheksen-1-karboksylsyre-etylester
MX9800694A (es) La preparacion de cicloalcanos quirales tales como endo-5-norbornen-2-ol.